Neuphoria Therapeutics (NEUP) Shares Outstanding (2022 - 2025)
Historic Shares Outstanding for Neuphoria Therapeutics (NEUP) over the last 4 years, with Q4 2025 value amounting to $5.4 million.
- Neuphoria Therapeutics' Shares Outstanding rose 23016.91% to $5.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 million, marking a year-over-year increase of 23016.91%. This contributed to the annual value of $2.0 million for FY2025, which is N/A changed from last year.
- According to the latest figures from Q4 2025, Neuphoria Therapeutics' Shares Outstanding is $5.4 million, which was up 23016.91% from $2.4 million recorded in Q3 2025.
- Neuphoria Therapeutics' 5-year Shares Outstanding high stood at $969.4 million for Q2 2022, and its period low was $454465.1 during Q2 2023.
- For the 4-year period, Neuphoria Therapeutics' Shares Outstanding averaged around $123.1 million, with its median value being $1.9 million (2025).
- Per our database at Business Quant, Neuphoria Therapeutics' Shares Outstanding tumbled by 9995.31% in 2023 and then skyrocketed by 23016.91% in 2025.
- Neuphoria Therapeutics' Shares Outstanding (Quarter) stood at $969.4 million in 2022, then crashed by 99.95% to $454465.1 in 2023, then soared by 258.37% to $1.6 million in 2024, then surged by 230.17% to $5.4 million in 2025.
- Its last three reported values are $5.4 million in Q4 2025, $2.4 million for Q3 2025, and $2.0 million during Q2 2025.